• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 09-09-2025: General Updates

    09-09-2025 | 08:48 am

    Glenmark's subsidiary, IGI, received an upfront payment of $700 million from AbbVie. This is for an exclusive global licensing agreement of IGI’s lead investigational asset, ISB 2001, across major markets.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited